Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -3042.18% is 23% below its 2-year average of -2477.16%, near the high end of its 2-year range (-12831.49%–-125.30%).
68.46% below its 12-month average of -1805.89%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2025 (2025-06-30): -1139.68%.
EBITDA MARGIN
-3042.18%
EBITDA MARGIN AVG TTM
-1805.89%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-68.46%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$2.02B
EBITDA Margin
40.34%
TTM Avg
23.31%
3Y Avg
-20.04%
5Y Avg
-112.62%
Market Cap
$2.01B
EBITDA Margin
1.74%
TTM Avg
-0.52%
3Y Avg
3.36%
5Y Avg
2.51%
Market Cap
$2.05B
EBITDA Margin
7.12%
TTM Avg
6.21%
3Y Avg
-1.19%
5Y Avg
-11.55%
Market Cap
$2.06B
EBITDA Margin
39.14%
TTM Avg
19.43%
3Y Avg
-11.55%
5Y Avg
-189.29%
Market Cap
$1.96B
EBITDA Margin
-13.52%
TTM Avg
-19.53%
3Y Avg
-24.36%
5Y Avg
-23.78%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunome, Inc. (IMNM) | $2.02B | -3042.18% | -1805.89% | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 40.34% | 23.31% | -20.04% | -112.62% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 1.74% | -0.52% | 3.36% | 2.51% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 7.12% | 6.21% | -1.19% | -11.55% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | 0.15% | 1.29% | -6.34% | -9.86% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | 39.14% | 19.43% | -11.55% | -189.29% |
| Alvotech (ALVO)vs › | $2.07B | 19.79% | 20.20% | -178.47% | -247.76% |
| Azenta, Inc. (AZTA)vs › | $1.97B | 8.41% | 9.50% | 6.21% | 7.73% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -13.52% | -19.53% | -24.36% | -23.78% |
| Absci Corporation (ABSI)vs › | $1.95B | -4034.86% | -3070.57% | -2386.79% | -1872.66% |
Gross Margin
57.4%
EBITDA Margin
-3042.2%
Operating Margin
-3084.8%
Net Margin
-3060.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2025-06-30 | -1139.68% |
| 2025-03-31 | -1500.68% |
| 2024-12-31 | -3008.58% |
| 2024-09-30 | -1716.53% |
| 2024-06-30 | -1663.96% |
| 2024-03-31 | -12831.49% |
| 2023-12-31 | -2467.22% |
| 2023-09-30 | -125.30% |
| 2023-06-30 | -133.05% |
| 2023-03-31 | -185.15% |
